RARA and steatosis: Mice expressing liver-specific RARα dominant negative protein exhibited microalveolar steatosis at 4 months, decreased mitochondrial β-oxidized fatty acids, and developed hepatocellular carcinoma and hepatic adenoma at 1 month (Yanagitani et al., 2004).